Aslan Pharmaceuticals Valuation
| ASLN Stock | USD 0.54 0.05 10.20% |
Aslan Pharmaceuticals is undervalued. Aslan Pharmaceuticals shows a prevailing Real Value of $4.32 per share. The current price of the firm is $0.54. Our model approximates the value of Aslan Pharmaceuticals from analyzing the firm fundamentals such as Operating Margin of (3.64) %, shares outstanding of 22.63 M, and Return On Equity of -4.27 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Aslan Pharmaceuticals' valuation include:
Price Book 2.1426 | Enterprise Value 238.9 M | Enterprise Value Ebitda (0.22) | Price Sales 0.9432 | Enterprise Value Revenue 0.7356 |
Undervalued
Today
Please note that Aslan Pharmaceuticals' price fluctuation is extremely dangerous at this time. Calculation of the real value of Aslan Pharmaceuticals is based on 3 months time horizon. Increasing Aslan Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Aslan Pharmaceuticals Ltd is useful when determining the fair value of the Aslan stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Aslan Pharmaceuticals. Since Aslan Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aslan Stock. However, Aslan Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.54 | Real 4.32 | Target 15.67 | Hype 0.52 |
The real value of Aslan Stock, also known as its intrinsic value, is the underlying worth of Aslan Pharmaceuticals Company, which is reflected in its stock price. It is based on Aslan Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Aslan Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aslan Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aslan Pharmaceuticals Ltd helps investors to forecast how Aslan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aslan Pharmaceuticals more accurately as focusing exclusively on Aslan Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Aslan Pharmaceuticals' intrinsic value based on its ongoing forecasts of Aslan Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Aslan Pharmaceuticals' closest peers. When choosing an evaluation method for Aslan Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Aslan Pharmaceuticals Investments |
|
Aslan Valuation Drivers Correlation
Many accounts on the financial statements of Aslan Pharmaceuticals are highly interrelated and sometimes correlated. Consequently, when conducting Aslan's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Aslan
Click cells to compare fundamentals
Aslan Valuation Trend
Knowing Aslan Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Aslan Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Aslan Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Aslan Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Aslan Market Cap
Aslan Pharmaceuticals Ltd is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 9.34 Billion. Aslan Pharmaceuticals adds roughly 12.22 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Aslan Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Aslan Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Aslan Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aslan Pharmaceuticals competition to find correlations between indicators driving Aslan Pharmaceuticals's intrinsic value. More Info.Aslan Pharmaceuticals Ltd is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . As of the 19th of April 2024, Price To Book Ratio is likely to drop to -0.68. Comparative valuation analysis is a catch-all model that can be used if you cannot value Aslan Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aslan Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aslan Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aslan Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aslan Pharmaceuticals and how it compares across the competition.
About Aslan Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Aslan Pharmaceuticals Ltd on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Aslan Pharmaceuticals Ltd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Aslan Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Aslan Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Aslan Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aslan Pharmaceuticals. We calculate exposure to Aslan Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aslan Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.7 M | 12.2 M | |
| Pretax Profit Margin | (4.22) | (4.44) | |
| Operating Profit Margin | (4.19) | (4.40) | |
| Net Loss | (4.24) | (4.45) | |
| Gross Profit Margin | 1.12 | 1.03 |
8 Steps to conduct Aslan Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Aslan Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aslan Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Aslan Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Aslan Pharmaceuticals' revenue streams: Identify Aslan Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Aslan Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Aslan Pharmaceuticals' growth potential: Evaluate Aslan Pharmaceuticals' management, business model, and growth potential.
- Determine Aslan Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aslan Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Aslan Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Aslan Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 16.4 M |
Aslan Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Aslan Pharmaceuticals Ltd and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Aslan we look at many different elements of the entity such as Aslan's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Aslan Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Aslan Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aslan Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aslan Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aslan Pharmaceuticals' worth.When determining whether Aslan Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aslan Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aslan Pharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aslan Pharmaceuticals Ltd Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aslan Pharmaceuticals Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Aslan Stock analysis
When running Aslan Pharmaceuticals' price analysis, check to measure Aslan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aslan Pharmaceuticals is operating at the current time. Most of Aslan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aslan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aslan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aslan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Aslan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aslan Pharmaceuticals. If investors know Aslan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aslan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.75) | Revenue Per Share 0.746 | Return On Assets (0.64) | Return On Equity (4.27) |
The market value of Aslan Pharmaceuticals is measured differently than its book value, which is the value of Aslan that is recorded on the company's balance sheet. Investors also form their own opinion of Aslan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aslan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aslan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aslan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aslan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aslan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aslan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.